Lensar (LNSR) EPS (Weighted Average and Diluted) (2021 - 2026)
Lensar (LNSR) reported EPS (Weighted Average and Diluted) of $0.0 for Q1 2026, up 100.1% year-over-year from $0.0 in Q1 2025, and up 101.89% quarter-over-quarter from -$0.12 in Q4 2025.
Lensar (LNSR) EPS (Weighted Average and Diluted) (2021 - 2026) Analysis & Trends
Lensar (LNSR) has 6 years of EPS (Weighted Average and Diluted) data on file, last reported at $0.0 in Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at $0.0, up 100.1% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.58 (up 88.07% YoY), and the FY2025 annual result was -$2.87, down 5.13% from the prior year.
- EPS (Weighted Average and Diluted) grew to $0.0 in Q1 2026 per LNSR's latest filing, from -$0.12 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $0.0 in Q1 2026 and troughed at -$2.32 in Q1 2025.
- A 5-year average of -$0.55 and a median of -$0.35 in 2023 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2025 and 2026: EPS (Weighted Average and Diluted) plunged 1121.05% in 2025, then soared 100.1% in 2026.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.23 in 2022, then sank by 52.17% to -$0.35 in 2023, then tumbled by 362.86% to -$1.62 in 2024, then jumped by 92.59% to -$0.12 in 2025, then soared by 101.89% to $0.0 in 2026.
- Business Quant data shows LNSR's EPS (Weighted Average and Diluted) at $0.0 in Q1 2026, -$0.12 in Q4 2025, and -$0.31 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.24 |
| 10 | Lensar | 70.05 Mn | 70.34 Mn | 6.38 Mn | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | -0.12 |
| Sep 30, 2025 | -0.31 |
| Jun 30, 2025 | -0.15 |
| Mar 31, 2025 | -2.32 |
| Dec 31, 2024 | -1.62 |
| Sep 30, 2024 | -0.13 |
| Jun 30, 2024 | -0.79 |
| Mar 31, 2024 | -0.19 |
| Dec 31, 2023 | -0.35 |
| Sep 30, 2023 | -0.23 |
| Jun 30, 2023 | -0.81 |
| Mar 31, 2023 | -0.40 |
| Dec 31, 2022 | -0.23 |
| Sep 30, 2022 | -0.39 |
| Jun 30, 2022 | -0.67 |
| Mar 31, 2022 | -0.67 |
| Dec 31, 2021 | -0.40 |
| Sep 30, 2021 | -0.65 |
| Jun 30, 2021 | -0.47 |